Bringing the fundamentals into focus…
Back to Emergent BioSolutions Inc.
How Emergent BioSolutions Inc. stacks up
EBS · against 588 other Healthcare companies listed in US-listed
Valuation
79/ 100
Near the top of its peers.
Ranked #56 of 589 · scores higher than 90% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 70–79, including EBS · Click a bar to see the companies
Why valuation scores 79?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -54.4% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 97% of peers. EBITDA yield: 30.5% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 98% of peers. Free cash flow yield: 26.8% vs peer median 0.0%
Metric by metric
Position: dot = EBS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | EBS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -54.4% | -4.3% | 9% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 30.5% | -0.8% | 96% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 26.8% | -2.3% | 98% | 20% | |
| Book yieldHigher is better · 587 reported | 106.5% | 25.9% | 91% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around EBS| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 52 | 1.7B USD | 80 | 44 | |
| 52 | Unavailable | 80 | 56 | |
| 52 | 1.8B USD | 80 | 80 | |
| 52 | 2.3B USD | 80 | 52 | |
| 56 | 320M USD | 79 | 44 | |
| 56 | 418M USD | 79 | 74 | |
| 58 | 393M USD | 78 | 61 | |
| 59 | 10.7B USD | 77 | 78 | |
| 60 | 89.7B USD | 76 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score